Galt Pharms patents expiration
1. Doral patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7608616 | GALT PHARMS | Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia |
Jun, 2028
(4 years from now) | |
Drugs and Companies using QUAZEPAM ingredient
Market Authorisation Date: 26 February, 1987
Treatment: Method for treating insomnia while reducing the risk of an adverse drug interaction
Dosage: TABLET;ORAL
More Information on Dosage
DORAL family patents
2. Oravig patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7651698 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(1 year, 7 months ago) | |
| US6916485 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(1 year, 7 months ago) | |
| US8518442 | GALT PHARMS | Prolonged release bioadhesive therapeutic systems |
Sep, 2022
(1 year, 7 months ago) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Dosage Form(NDF) | Apr 16, 2013 |
Drugs and Companies using MICONAZOLE ingredient
Market Authorisation Date: 16 April, 2010
Treatment: Treatment of oropharyngeal candidiasis
Dosage: TABLET;BUCCAL
More Information on Dosage
ORAVIG family patents